Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laura Shawver currently holds 59,064 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laura Shawver has been a net seller of SPRY stock. They have purchased $0 and sold $3.6M worth of shares.
Laura Shawver's most recent insider trade was on Dec 4, 2024, when they sold 14,772 shares at $0.00 per share.
Laura Shawver serves as Executive at ARS Pharmaceuticals, Inc. (SPRY). They have executed 49 insider transactions totaling $3.6M over their tenure at the company.
Laura Shawver holds the position of Executive at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Laura Shawver has shown a selling trading pattern, with $0 in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Laura Shawver was on Jan 23, 2020, when they sold $15.0M worth of THOR shares. This transaction involved 220,595 shares at $68.00 per share.
Laura Shawver currently owns 59,064 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laura Shawver's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laura Shawver has 49 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Laura Shawver and 40,000+ other insiders.